Overview

Concurrent Immunotherapy With Postoperative Radiotherapy in Intermediate/High Risk HNSCC Patients Unfit for Cisplatin: The IMPORT Study (IMPORT)

Status:
Recruiting

Trial end date:
2024-08-09

Target enrollment:

Participant gender:

Summary

To investigate weather concurrent JS001 with postoperative radiotherapy would have survival benefit in intermediate/high Risk HNSCC Patients who cannot take cisplatin

Phase:

Phase 2

Details

Lead Sponsor:

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Collaborators:

Central South University
Eye & ENT Hospital of Fudan University
Eye and ENT Hospital of Fudan University
First Affiliated Hospital of Fujian Medical University
Fudan University
Guizhou Provincial People's Hospital
Tianjin Medical University Cancer Institute and Hospital